Francomano Robert
Insider CIK 1797467 · STML Chief Commercial Officer · SLS Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLS SELLAS Life Sciences Group | A Award deriv | 2024-01-22 | 2024-01-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2024-01-22 | 2024-01-25 | 20,000 | — | $0 | 40,918 | SEC↗ |
| SLS SELLAS Life Sciences Group | J Other | 2023-12-06 | 2023-12-08 | 1,082 | $1.08 | $1.2K | 20,918 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2023-02-02 | 2023-02-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2023-02-02 | 2023-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2022-03-14 | 2022-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | D To issuer deriv | 2020-06-10 | 2020-06-10 | 50,000 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | U Tender | 2020-06-10 | 2020-06-10 | 200,891 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2020-05-04 | 2020-05-06 | 272 | $11.51 | $3.1K | 197,658 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2020-03-09 | 2020-03-13 | 1,266 | $5.00 | $6.3K | 197,930 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2020-02-10 | 2020-02-14 | 105,939 | — | $0 | 199,196 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2020-02-07 | 2020-02-14 | 5,064 | $6.72 | $34.0K | 93,257 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2019-12-27 | 2020-01-03 | 116 | $10.48 | $1.2K | 98,321 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2019-12-26 | 2020-01-03 | 893 | $10.75 | $9.6K | 98,437 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2019-12-24 | 2020-01-03 | 1,412 | $10.97 | $15.5K | 99,330 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2019-12-23 | 2020-01-03 | 249 | $10.58 | $2.6K | 100,742 | SEC↗ |